Dr. Michael Anthony Dellavecchia, FACS, MD, PhD

Dr. Dellavecchia practices at Lankenau Medical Center in Wayne, Pennsylvania.

Dr. Dellavecchia's NPI, 1437172277, was assigned on July 25, 2006. Dr. Dellavecchia graduated from Lewis Katz School of Medicine in 1976. Dr. Dellavecchia holds Pennsylvania license MD020408E.

Dr. Dellavecchia's primary practice is Lankenau Medical Center, at 100 E Lancaster Ave, Wayne, PA 19087 in Delaware County. The practice phone is (610) 645-2000.

Dr. Dellavecchia's primary practice is Lankenau Medical Center in Wayne, Pennsylvania. Dr. Dellavecchia is also affiliated with Lankenau Medical Center. Dmand AI also links Dr. Dellavecchia to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dellavecchia practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dellavecchia's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Dellavecchia is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dellavecchia's licenses on file in 2 states: Pennsylvania and New Jersey.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Dellavecchia treats.

CMS data shows 693 Medicare services from Dr. Dellavecchia across 10 procedure codes in 2024, for 486 Medicare patients. Medicare paid $47,757 for them. Every service was in an office.

CMS counts 486 Medicare patients who saw Dr. Dellavecchia in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dellavecchia's median patient age at 63, with 54% women.

In 2024, Dr. Dellavecchia wrote 302 Medicare Part D claims for 130 patients. 70% of them were for generic drugs. CMS names the drug for 223 of them, across 8 drugs with 11 or more claims each, at $21,760 in total drug cost. In 2023, CMS named 176 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Dellavecchia for performance year 2024, reported as part of a group. Dr. Dellavecchia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Dellavecchia. Dr. Dellavecchia's most frequent co-authors are Thomas S. Boland, MD, Murray Lewis Friedberg, MD and Jodi Ian Luchs, MD.

Dmand AI links Dr. Dellavecchia to 1 clinical trial. Conditions studied include Conjunctivitis, Viral and Keratoconjunctivitis.

CMS Open Payments shows 49 general payments to Dr. Dellavecchia from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Shire North American Group Inc paid the most, $490.

Dmand AI lists 20 awards for Dr. Dellavecchia, most recently Governor in 2016.

Dr. Dellavecchia graduated from Lewis Katz School of Medicine in 1976. Dr. Dellavecchia is a member of American Academy of Ophthalmology, AAO, ACS, AMA, American Society of Lasers in Medicine and Surgery and College of Physicians of Philadelphia.

Dr. Dellavecchia is in network with 25 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 15. Check the plan with the practice before a visit.